TheProfitWatch

MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.35 0.06 (4.44%) --- --- 0.01 (0.71%) -0.02 (-1.48%) 0.08 (6.02%) 0.06 (4.39%) 0.0 (-0.11%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.09
Diluted EPS:
-0.09
Basic P/E:
-15.6667
Diluted P/E:
-15.6667
RSI(14) 1m:
57.14
VWAP:
1.41
RVol:

Events

Period Kind Movement Occurred At

Related News